Porton Pharma (Jiangxi) Co., Ltd., founded in 2007, a wholly owned subsidiary of Porton Pharma Solutions Ltd. (stock code:?300363), located in Fengxin High-tech industrial park, Jiangxi province with 50 kilometers away from Nanchang, is a high-tech pharmaceutical enterprise with R&D, manufacturing and trading combination; and is the enterprise technology center of Jiangxi province, the technology innovation demonstration enterprises of Yichun city, the top 50 manufacturing enterprises and the first lot of healthy enterprises of Yichun.? The company covers an area of 114,000m2, which is designed upon GMP standards and meets the production requirements of GMP. It is mainly engaged in the research and development, production and sales of intermediates of anti-AIDS drugs, Iodine contrast agents and so on.

　　The company pays attention to enterprise construction and pushes forward the international advanced management theory in the management. Besides of the implementation of IS09001 international quality management system, system construction was also built referring to the requirements of CGMP;?The company has adopted the international standard EHS management system (ISO14001 and ISO45001, etc.);?various kinds of trainings are doing for all staffs, which improves the production and management level and enhances the competitiveness of the company.

　　Company has perfect production equipment and facilities, complete supporting functions, and realized the unity of enterprise benefit, social benefit and ecological benefit.?Company has complete testing equipment, relying on the technical support of Shanghai, Chengdu, Chongqing R & D center, the products are mainly exported to Europe and America and other countries, well received by customers

　　Porton is committed to becoming the most open, innovative and reliable pharmaceutical service platform in the world. From intermediates, APIs to formulations, Porton focuses on providing excellent end-to-end CDMO services to the global customers, striving to make good drugs benefit the public earlier.